RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL

This article provides a retrospective analysis of a case of adverse drug reactions to the drug haloperidol - neuroleptic malignant syndrome. A literature review on the issue of neuroleptic malignant syndrome was represented. The factors that led to this syndrome development of a particular patient w...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Arkhipov (Author), N. G. Berdnikova (Author), M. V. Zhuravleva (Author), V. G. Kukes (Author)
Format: Book
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3cb83c92dcbb47a78a8712c33ecce932
042 |a dc 
100 1 0 |a V. V. Arkhipov  |e author 
700 1 0 |a N. G. Berdnikova  |e author 
700 1 0 |a M. V. Zhuravleva  |e author 
700 1 0 |a V. G. Kukes  |e author 
245 0 0 |a RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL 
260 |b Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,   |c 2018-02-01T00:00:00Z. 
500 |a 2312-7821 
500 |a 2619-1164 
520 |a This article provides a retrospective analysis of a case of adverse drug reactions to the drug haloperidol - neuroleptic malignant syndrome. A literature review on the issue of neuroleptic malignant syndrome was represented. The factors that led to this syndrome development of a particular patient were evaluated. Detailed clinical and pharmacological value of gene polymorphism CYP 2D6 is discussed. The data on the successful use of a therapy of neuroleptic malignant syndrome with ethylmethylhydroxypyridine malat are presented. 
546 |a RU 
690 |a нежелательная реакция 
690 |a злокачественный нейролептический синдром 
690 |a полиморфизм гена cyp 2d6 
690 |a этилметилгидроксипиридина малат 
690 |a adverse reaction 
690 |a neuroleptic malignant syndrome 
690 |a gene polymorphism cyp 2d6 
690 |a etilmetilgidroksipiridin malat 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 30-39 (2018) 
787 0 |n https://www.risksafety.ru/jour/article/view/13 
787 0 |n https://doaj.org/toc/2312-7821 
787 0 |n https://doaj.org/toc/2619-1164 
856 4 1 |u https://doaj.org/article/3cb83c92dcbb47a78a8712c33ecce932  |z Connect to this object online.